technologynetworks

PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery Programs

PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal ...
PharmiWeb

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programs Platform will ...
Yahoo Finance

Salipro Biotech and Boehringer Ingelheim Enter Research and License Agreement to Accelerate Multiple Boehringer Ingelheim Pipeline Programs

STOCKHOLM, March 13, 2025 (GLOBE NEWSWIRE) -- Salipro Biotech AB, a Swedish biotech company specialising in the stabilisation of challenging drug targets, today announced a research and license ...
Investing

Exscientia advances two drug programs with Sanofi

OXFORD, England - Exscientia plc (NASDAQ:EXAI) has reached significant milestones in its collaboration with pharmaceutical giant Sanofi (NASDAQ:SNY), advancing two drug discovery programs to the lead ...